The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation
Details
Publication Year 2020-10,Volume 21,Issue #10,Page 1205-1218
Journal Title
Nature Immunology
Publication Type
Journal Article
Abstract
Immune-modulating therapies have revolutionized the treatment of chronic diseases, particularly cancer. However, their success is restricted and there is a need to identify new therapeutic targets. Here, we show that natural killer cell granule protein 7 (NKG7) is a regulator of lymphocyte granule exocytosis and downstream inflammation in a broad range of diseases. NKG7 expressed by CD4(+) and CD8(+) T cells played key roles in promoting inflammation during visceral leishmaniasis and malaria-two important parasitic diseases. Additionally, NKG7 expressed by natural killer cells was critical for controlling cancer initiation, growth and metastasis. NKG7 function in natural killer and CD8(+) T cells was linked with their ability to regulate the translocation of CD107a to the cell surface and kill cellular targets, while NKG7 also had a major impact on CD4(+) T cell activation following infection. Thus, we report a novel therapeutic target expressed on a range of immune cells with functions in different immune responses.
Publisher
NPG
Research Division(s)
Blood Cells And Blood Cancer
PubMed ID
32839608
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2020-10-02 09:53:37
Last Modified: 2020-10-02 10:07:24
An error has occurred. This application may no longer respond until reloaded. Reload 🗙